290 related articles for article (PubMed ID: 12435679)
1. Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine.
Tatsumi Y; Yokoo M; Senda H; Kakehi K
Antimicrob Agents Chemother; 2002 Dec; 46(12):3797-801. PubMed ID: 12435679
[TBL] [Abstract][Full Text] [Related]
2. The low keratin affinity of efinaconazole contributes to its nail penetration and fungicidal activity in topical onychomycosis treatment.
Sugiura K; Sugimoto N; Hosaka S; Katafuchi-Nagashima M; Arakawa Y; Tatsumi Y; Jo Siu W; Pillai R
Antimicrob Agents Chemother; 2014 Jul; 58(7):3837-42. PubMed ID: 24752277
[TBL] [Abstract][Full Text] [Related]
3. In vitro antifungal activity of KP-103, a novel triazole derivative, and its therapeutic efficacy against experimental plantar tinea pedis and cutaneous candidiasis in guinea pigs.
Tatsumi Y; Yokoo M; Arika T; Yamaguchi H
Antimicrob Agents Chemother; 2001 May; 45(5):1493-9. PubMed ID: 11302816
[TBL] [Abstract][Full Text] [Related]
4. In vivo fungicidal effect of KP-103 in a guinea pig model of interdigital tinea pedis determined by using a new method for removing the antimycotic carryover effect.
Tatsumi Y; Yokoo M; Arika T; Yamaguchi H
Microbiol Immunol; 2002; 46(7):433-9. PubMed ID: 12222929
[TBL] [Abstract][Full Text] [Related]
5. KP-103, a novel triazole derivative, is effective in preventing relapse and successfully treating experimental interdigital tinea pedis and tinea corporis in guinea pigs.
Tatsum Y; Yokoo M; Arika T; Yamaguchi H
Microbiol Immunol; 2002; 46(7):425-32. PubMed ID: 12222928
[TBL] [Abstract][Full Text] [Related]
6. [Effectiveness of oral treatment with terbinafine in a guinea pig model of tinea pedis].
Uchida K; Yamaguchi H
Jpn J Antibiot; 1994 Oct; 47(10):1401-6. PubMed ID: 7807699
[TBL] [Abstract][Full Text] [Related]
7. [A study on effectiveness of treatment and prevention of relapse using topical administration of terbinafine in a guinea pig model for tinea pedis].
Uchida K; Kudoh M; Yamaguchi H
Jpn J Antibiot; 1994 Oct; 47(10):1407-12. PubMed ID: 7807700
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of AS2077715 against experimental tinea pedis in guinea pigs in comparison with terbinafine.
Ohsumi K; Murai H; Nakamura I; Watanabe M; Fujie A
J Antibiot (Tokyo); 2014 Oct; 67(10):717-9. PubMed ID: 24865864
[TBL] [Abstract][Full Text] [Related]
9. An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis.
Jaiswal A; Sharma RP; Garg AP
Indian J Dermatol Venereol Leprol; 2007; 73(6):393-6. PubMed ID: 18032857
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial.
Auvinen T; Tiihonen R; Soini M; Wangel M; Sipponen A; Jokinen JJ
Br J Dermatol; 2015 Oct; 173(4):940-8. PubMed ID: 26036329
[TBL] [Abstract][Full Text] [Related]
11. Preparation and
Lee BC; Pangeni R; Na J; Koo KT; Park JW
Drug Deliv; 2019 Dec; 26(1):1167-1177. PubMed ID: 31738083
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and Efficacy of Two Topical Therapeutic Agents for Onychomycosis.
Kawai M
Med Mycol J; 2019; 60(3):71-74. PubMed ID: 31474693
[TBL] [Abstract][Full Text] [Related]
13. Terbinafine: an oral and topical antifungal agent.
Shear NH; Villars VV; Marsolais C
Clin Dermatol; 1991; 9(4):487-95. PubMed ID: 1840406
[No Abstract] [Full Text] [Related]
14. Onychomycosis: Strategies to Minimize Recurrence.
Gupta AK; Elewski BE; Rosen T; Caldwell B; Pariser DM; Kircik LH; Bhatia N; Tosti A
J Drugs Dermatol; 2016 Mar; 15(3):279-82. PubMed ID: 26954312
[TBL] [Abstract][Full Text] [Related]
15. Sporicidal effect of amorolfine and other antimycotics used in the therapy of fungal nail infections.
Seidl HP; Jäckel A; Müller J; Schaller M; Borelli C; Polak A
Mycoses; 2015 Oct; 58(10):610-9. PubMed ID: 26334024
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic Dermatophytes Survive in Nail Lesions During Oral Terbinafine Treatment for Tinea Unguium.
Iwanaga T; Ushigami T; Anzawa K; Mochizuki T
Mycopathologia; 2017 Aug; 182(7-8):673-679. PubMed ID: 28281037
[TBL] [Abstract][Full Text] [Related]
17. Efficacy Coefficients Determined Using Nail Permeability and Antifungal Activity in Keratin-Containing Media Are Useful for Predicting Clinical Efficacies of Topical Drugs for Onychomycosis.
Matsuda Y; Sugiura K; Hashimoto T; Ueda A; Konno Y; Tatsumi Y
PLoS One; 2016; 11(7):e0159661. PubMed ID: 27441843
[TBL] [Abstract][Full Text] [Related]
18. [Topical terbinafine. Reduction of duration of therapy for tinea pedis].
Schmid-Wendtner MH; Korting H
Hautarzt; 2008 Dec; 59(12):986-91. PubMed ID: 18987841
[TBL] [Abstract][Full Text] [Related]
19. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement.
Baran R; Sigurgeirsson B; de Berker D; Kaufmann R; Lecha M; Faergemann J; Kerrouche N; Sidou F
Br J Dermatol; 2007 Jul; 157(1):149-57. PubMed ID: 17553051
[TBL] [Abstract][Full Text] [Related]
20. German randomized double-blind multicentre comparison of terbinafine and itraconazole for the treatment of toenail tinea infection.
Bräutigam M; Nolting S; Schopf RE; Weidinger G
Br J Dermatol; 1996 Jun; 134 Suppl 46():18-21: discussion 38. PubMed ID: 8763463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
